With a new method to synthesize DNA, San Diego's Molecular Assemblies notches $24M Series A

A San Diego biotech is taking a closer look at the way synthetic DNA is engineered, aiming to potentially revamp the decades-old process and serve as a partner to companies without the resources to create the DNA themselves.